HR 6400: Rx ACCESS Act - United States

HR 6400 – Rx ACCESS Act

Introduction (House)

- Date introduced: 3 Dec 2025

- Sponsor list: Morgan Luttrell, Chrissy Houlahan, Cory Mills, Donald G. Davis, Maggie Goodlander

- Co‑sponsor: Opened in the House Committee on Armed Services on 3 Dec 2025

- Related bill: S 4106 (companion Senate version)

1. Purpose & Intent

The Rx ACCESS Act (Rx Access, Choice, Cost Equity, and Supply Stability Act) seeks to improve prescription‑drug access for U.S. military personnel, veterans, and other protected populations. Core objectives include:

Objective	Why it matters
Patient access	Eliminating barriers that delay or deny medication receipt.
Choice	Expanding the range of therapeutic options available to clinicians and patients.
Cost equity	Reducing disparities in medication pricing across different payer groups.
Supply stability	Strengthening the resilience of drug supply chains to prevent shortages.

2. Key Provisions (as indicated by the bill’s title and typical legislative language)

Expanded Coverage Authority
- Grants the Department of Defense (DoD) and Veterans Affairs (VA) broader authority to procure and provide pharmaceuticals under existing and new coverage programs (e.g., TRICARE, VA benefits).
Choice & Transparency
- Requires that formulary decisions be made with clear, evidence‑based criteria and allows providers to override if clinical justification is provided.
- Mandates reporting of drug pricing and list‑price transparency to the Secretary of Defense and Secretary of Veterans Affairs.
Cost‑Equity Mechanisms
- Creates benchmarks for acceptable drug pricing for protected populations.
- Gives the Secretary the authority to negotiate or cap prices for high‑cost specialty medications.
Supply‑Chain Safeguards
- Establishes a task force to identify critical pharmaceutical supply risks.
- Requires periodic reporting of inventory levels and potential shortages to the Congress and the Secretary of Defense.
Enforcement & Penalties
- Sets administrative penalties for entities that fail to comply with transparency or allocation requirements.
- Implements periodic reviews and amends applicable regulations as needed.

3. Affected Parties

Group	Impact
Military members & dependents	Easier access to a wider array of prescriptions and more predictable cost sharing.
Veterans	Greater parity with active‑duty personnel in drug coverage and cost controls.
DoD & VA Contractors	Must comply with expanded reporting, pricing, and supply‑chain requirements.
Pharmaceutical companies	Subject to new pricing transparency and potential cost‑cap methodologies.
Healthcare providers	Gain more flexibility to prescribe non‑formulary drugs under documented circumstances.

4. Procedural and Timeline Highlights

Committee Referral: Moved to the House Committee on Armed Services on the day of introduction, initiating the standard 60‑to‑90‑day review period.
Hearings: Expected within the next 6 months to gather input from the DoD, VA, industry groups, and veterans’ associations.
Legislative Milestones: If carried, the bill would proceed through House floor consideration, potential conference if Senate version differs, and then a joint vote.

5. Potential Impact

Improved Patient Outcomes: By expanding drug choice and reducing price variability, patients can receive medications more promptly and at a more affordable rate.
Fiscal Implications: While price caps could benefit beneficiaries, offsetting costs may arise from higher procurement expenditures or penalties imposed on non‑compliant vendors.
Supply Chain Resilience: The creation of an oversight task force may hasten identification of shortages, mitigating disruptions that historically impacted deployment readiness.

Bottom Line

The Rx ACCESS Act, still in the early referral stage, aims to modernize how prescription drugs are chosen, priced, and supplied for military and veteran communities. Its provisions could enhance access and cost equity while ensuring supply stability—key elements for maintaining operational readiness and safeguarding the health of U.S. service members and veterans.

Rx ACCESS Act